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SUMMARY
Antibodies develop to injected insulin frequent-
ly. The development of anti-insulin antibodies is
maximum to conventional bovine insulin com-
pared to the porcine variety. The immunogenicity
of the insulin is not only due to the species from
which the insulin is prepared but also the im-
purities that are present in the preparation like
proinsulin and other islet ceil hormones. Hence
the purified insulins produce lesser amount of
antibodies and among the purified insulins, the
least is produced by human insulin.
The production of these antibodies depends on
the insulin preparation, the route of administra-
tion, age and sex and the genetic status of the in-
dividuals. These antibodies produce various com-
plications. They include allergy, lipoatrophy, in-
sulin resistance, alteration of metabolic control,
hypoglycemia, reduction in the duration of re-
mission period and fetal hypoglycemia when
given during the gestational period. These can be
overcome by the use of purified insulins.
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Insulin is commonly prescribed by the family physi-
cians for uncontrolled diabetes mellitus. In patients
who have insulin–dependent diabetes mellitus
(IDDM), exogenous insulin administration is manda-
tory. In another category called non-insulin dependent
diabetes mellitus (NIDDM) insulin administration is
recommended when there is severe hyperglycemia or
complicated diabetes. In gestational diabetes mellitus
(GDM), insulin injections are prescribed to maintain
normoglycemia.
In all these situations, insulin antibodies are pro-
duced in response to the administered insulin in pa-
tients. These insulin antibodies are responsible for
various complications, which can be avoided when
care is shown in choosing the right insulin prepara-
tion1. In the following article, the factors responsible
for the production of insulin (Table I), the complica-
tions they may produce (Table II) and the means by
which they can be overcome, are discussed.
Table I. Factors responsible for the formation of
anti-insulin antibodies
– Insulin Preparation
(i) Acidity of insulin
(ii) Adjuvants in insulin
(iii) Source of Insulin
– Route of administration
– Age and sex of the patient
– Genetic susceptibility
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Table II. Complications due to insulin antibody
– Insulin allergy
– Insulin resistance
– Lipoatrophy
Patients who develop insulin antibodies, require
more and more insulin for the control of diabetes and
subsequently develop insulin resistance. These pa-
tients benefit immensely when switched over to the
purified insulins. Their insulin requirement falls and the
antibody level decreases.
– Hypoglycemia Intravenous Vs Subcutaneous Route
– Shortening of remission period
– Fetal hyperinsulinemia and neonatal
hypoglycemia
INSULIN ANTIBODIES
Insulin antibodies develop several weeks after
starting of Insulin irrespective of whether it is beef,
pork or even human in origin. The antibodies develop
earlier to bovine insulin as compared to porcine in-
sulin2. The antibodies produced are of the IgG class.
Insulin antibodies may bind to insulin and form im-
mune complexes along with their attendant complica-
tions.
The degree of antibody formation depends on the
route of administration. A state of adaptation or toler-
ance is produced and negligible insulin antibodies are
formed when insulin is administered by continuous in-
travenous infusion. Breaks in insulin administration by
subcutaneous route are responsible for development
of heightened antibody response. This leads to the de-
velopment of insulin resistance. Administration of puri-
fied insulins in situations like surgery and pregnancy
would overcome this problem seen commonly with im-
pure insulins, which are otherwise called ‘dirty insu-
lins’.
Miscellaneous
pH of Insulin : The initial form of insulin that is ad-
ministered, determines the subsequent responsive-
ness to insulin. An acidic form of crystalline porcine in-
sulin produces a detectable antibody response com-
pared to the neutral form. If the neutral form of insulin
is given first, followed by the acidic form of insulin, the
level of antibodies produced is subsequently much
less.
The antibody production to injected insulin also de-
pends on the genetic susceptibiIity of the individual.
Patients who are HLA DR 7 postive show higher le-
vels of insulin antibody when compared to those with
HLA B84 who are unresponsive even to immunogenic
bovine insulin.
Adjuvants in Insulin : Zinc, which is present in the
long–acting preparation of insulin, is another determi-
nant to insulin antibody production. Protamine in Iso-
phane or NPH insulin is a substance that is often re-
sponsible for the production of insulin antibody. It is
derived from fish sperm and produces the highest
antibody levels in addition to allergy, and topical ad-
verse reactions at the injection site. It also stimulates
complement3.
Women tend to produce more antibody after six
months of treatment with beef isophane insulin. No
such sex difference has been seen with beef lente in-
sulin with advancing age. Further a decline in the anti-
body production is observed5.
COMPLICATIONS DUE TO INSULIN ANTIBODY
Source of Insulin : Discussing the origin of insulin,
bovine insulin is more immunogenic than porcine in-
sulin. Even purified bovine insulin is more immu-
nogenic than the purified porcine insulin. Comparing
human to porcine, purified human insulin is less immu-
nogenic. Therefore the inference that follows is that
purified insulins are better and purified human insulin
is even better. The purified insulin, which may be pure
at the time of preparation, if not maintained under
ideal conditions, develops the potential to produce
antibody when injected, due to the aggregation of the
insulin molecules. This factor could also be respon-
sible for the formation of insulin antibodies.
Allergy : Allergy to insulin is rare, but when it does
occur it can produce life-threatening complications.
The patient would give a prior history of treatment with
a bovine insulin and in testing with bovine insulin
would show wheal and flare reaction. Desensitisation
is often successful. In most instances, insulin allergy
occurs because of the zinc component of the insulin
preparation6.
Insulin Resistance : Insulin resistance per se is
rare. Patients with insulin resistance show high level
of insulin antibodies. Reduction in the insulin antibody
level reduces insulin requirements. Such a reduction
is brought about by switching from conventional to
purified insulins. The antibody–mediated insulin resist-
ance usually occurs during first year of treatment.
Nearly one–third of the patients with insulin resistance
also show insulin allergy. IgE is raised in insulin al-
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lergy but IgG is elevated in Insulin resistance. Desen-
sitisation may aggravate antibody-mediated insulin re-
sistance but the use of sulphated insulin would over-
come this resistance.
Lipoatrophy : Occurring at the site of insulin injec-
tion, lipoatrophy has an incidence of approximately
25% in patients treated with the conventional bovine
insulin. Lipoatrophy is a local form of immune complex
disease in which the insulin and the contaminating
protein along with antibody and complement, produce
local inflammation and destruction of the subcuta-
neous tissue. It seems to occur more in females than
males and these patients show elevated levels of anti-
insulin antibody. Patients taking purified insulin do not
develop lipoatrophy.
Miscellaneous : Unexplained hypoglycemia some-
times occurs in patients taking conventional bovine in-
sulin, due to dissociation of insulin from the insulin-anti
insulin antibody complex. The resulting increase in the
free insulin level causes this hypoglycemia. The disso-
ciation of insulin from the insulin-anti insulin antibody
complex occurs during carbohydrate restriction of in-
creased utilisation7.
Freshly detected diabetics in whom insulin is
started, often go into a “honeymoon” period. During
this period the insulin requirement falls and the patient
maintains euglycemia with the available endogenously
secreted insulin. This is also referred to as the re-
mission period. If the initial insulin administration is
conventional bovine insulin, the patients develop anti-
insulin antibodies. Those who develop anti-insulin
antibody come out of the remission period earlier and
present with severe disease.
Insulin that is injected normally does not cross the
placental barrier. It is only when insulin is bound to in-
sulin antibody, the insulin - antibody complex crosses
the placental barrier. Diabetic mothers who are to be
given conventional bovine insulin, may develop insulin
antibodies which form a complex and cross the
placental barrier. These complexes stimulate the fetal
pancreas. Insulin antibody belongs to IgG class, which
can cross the placenta on its own and stimulate the
fetal pancreas. Thus both insulin and proinsulin are re-
leased from the fetal pancreas. Increased carbohy-
drate utilization (available from the maternal circula-
tion) leads to the development of fetal macrosomia.
But soon after the delivery of the macrosomic fetus,
the non-availability of adequate carbohydrates which
were available from the maternal source, in the
presence of now excess insulin; produces neonatal
hypoglycemia.
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Doctors will have more lives to answer for in the next world.
than even we Generals
– Napoleon Bonaparte
THE JOURNAL OF GENERAL MEDICINE 49 APRIL – JUNE 1989 VOL. 1 No. 3
